FTSE100

Smith+Nephew to showcase JOURNEY™ II Unicompartmental Knee System at ESSKA Congress 2022

Retrieved on: 
Wednesday, April 27, 2022
Poster, NJR, HQIP, Hospital, Patient, LinkedIn, Technology, Markov, Hip, Unicompartmental knee arthroplasty, Forward-looking statement, European Society of Radiology, Healthcare Quality Improvement Partnership, Health, Regeneration, Annual report, ENT, EMEA, Sterilization, LSE, U.S. Securities and Exchange Commission, Medicine, UKA, AOA, Implant, Computer simulation, Congress, United States Patent and Trademark Office, Smith & Nephew, Group, Twitter, Traumatology, Failure, United States patent law, Phrase, Knee Surgery, Sports Traumatology, Arthroscopy, Form 20-F, Patent, SNN, ZUK, Isle, Sports medicine, FTSE100, NYSE, Instagram, Longevity, Unlimited, Medical device, Pharmaceutical industry, COVID-19, Facebook

LONDON, April 27, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will showcase its latest JOURNEY II Unicompartmental Knee (UK) System during the European Society of Sports Traumatology, Knee Surgery & Arthroscopy 2022 Congress being held in Paris, France.

Key Points: 
  • LONDON, April 27, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will showcase its latest JOURNEY II Unicompartmental Knee (UK) System during the European Society of Sports Traumatology, Knee Surgery & Arthroscopy 2022 Congress being held in Paris, France.
  • "Smith+Nephew has a successful legacy in the development of unicompartmental knee solutions and our JOURNEY II UK System is the next innovative chapter in that story.
  • JOURNEY II UK will be showcased as part of the Smith+Nephew Lunch Symposium "Overcoming UKA challenges with a new Implant Design and Handheld Robotics" at the ESSKA 2022 Congress on 29 April at 12:30pm CEST.
  • Nherera L, Verma S, Trueman P. Cost-effectiveness of robotic-assisted unicompartmental knee arthroplasty (r-UKA) using NAVIOTM compared to traditional unicompartmental knee arthroplasty (t-UKA) for patients with unicompartmental osteoarthritis.

Light & Wonder Extends Long-term Partnership With Entain

Retrieved on: 
Thursday, April 14, 2022
Sports, Electronic Games, Casino, Gaming, Entertainment, General Sports, Ring, Annual report, The Lord of the Rings, FTSE4Good Index, Lord, EMEA, Carbon, LSE, Sports Interactive, Culture, U.S. Securities and Exchange Commission, Security (finance), NASDAQ, Karhu (sports brand), Scientific Games, AA, Creativity, Private Securities Litigation Reform Act, Group, ESG, MSCI, Risk, PartyCasino, Form 10-K, Mission statement, Gambling, Partypoker, Growth, Technology, LBO, Company, FTSE100, DJSI, SEC, MGM Resorts International, Forward-looking statement, Partnership, Industry, Senior, Science, Ladbrokes Coral, Online gambling, Video game, Sportingbet, Entain, Light, Gala Bingo

Scientific Games Corporation , doing business as Light & Wonder , (NASDAQ: SGMS) (Light & Wonder, L&W or the Company) has extended its existing agreement with global sports betting, gaming and interactive entertainment group Entain through to 2030.

Key Points: 
  • Scientific Games Corporation , doing business as Light & Wonder , (NASDAQ: SGMS) (Light & Wonder, L&W or the Company) has extended its existing agreement with global sports betting, gaming and interactive entertainment group Entain through to 2030.
  • Light & Wonder will continue to supply over 10,000 terminals to Entains licensed betting offices (LBO) through their Coral and Ladbrokes retail shops.
  • Light & Wonder enhances that with the industrys best gaming machines backed up by a great range of leading games, service infrastructure and support, said Andy Hicks, Retail MD UK & Ireland at Entain.
  • We are delighted that Entain has chosen to continue our partnership through to 2030, said Simon Johnson, Senior Vice President & Managing Director, EMEA at Light & Wonder.

NetLine's 2022 Content Consumption Report Reveals Unequaled New Buyer-Level Intent Findings

Retrieved on: 
Wednesday, March 30, 2022
Behavior, White, Mental health, Annual report, Research, Marketing, Technology, FTSE100, Ebook, Intention, GLOBE, Acceleration, Acquisition, Sales, B2B

CAMPBELL, Calif., March 30, 2022 (GLOBE NEWSWIRE) -- Today, NetLine published its 2022 State of B2B Content Consumption and Demand Report for Marketers a full-scale look into the platform's first-party content consumption and demand data from the previous 12 months.

Key Points: 
  • CAMPBELL, Calif., March 30, 2022 (GLOBE NEWSWIRE) -- Today, NetLine published its 2022 State of B2B Content Consumption and Demand Report for Marketers a full-scale look into the platform's first-party content consumption and demand data from the previous 12 months.
  • The company's annual report explores key insights from the content consumption behaviors of millions of B2B buyers, providing a data-backed foundation through which Marketers can guide their centric content demand generation marketing programs.
  • Additionally, NetLine reported a 19% acceleration in additional content registrations and a 3.6-hour increase in overall time to consume content.
  • NetLine CEO Robert Alvin shared his thoughts on NetLine's 2022 report, specifically calling attention to the buyer-level intent findings.

Smith+Nephew announces new study showing GRAFIX™ Membrane cut the rate of diabetic foot ulcer recurrence in half compared to leading competitors

Retrieved on: 
Thursday, March 31, 2022
Public Health Service Act, NYSE, MiMedx, Stem cell, Technology, Phrase, Regeneration, Twitter, FTSE100, Membrane, Time, LSE, Extracellular matrix, Contraindication, Recurrence, DFU, Organogenesis, Tissue, View, U.S. Securities and Exchange Commission, Medicare, Policy, Smith & Nephew, SNN, ENT, Patent, Forward-looking statement, DPM, Ulcer, Mortality, Multimedia, Group, Annual report, Standard of care, Unlimited, Failure, Cellular, CFR, Instagram, Patient, United States patent law, Form 20-F, LinkedIn, United States Patent and Trademark Office, CTPS, CTP, Longevity, Facebook, Diabetic foot ulcer, Sports medicine, Pharmaceutical industry, Medical imaging, Medicine, COVID-19

It compared ulcer recurrence rates, patient mortality, and other outcomes at 30-, 90-, 180-, and 365-days for GRAFIX Membrane vs. Cellular CTPs and vs. Acellular CTPs.

Key Points: 
  • It compared ulcer recurrence rates, patient mortality, and other outcomes at 30-, 90-, 180-, and 365-days for GRAFIX Membrane vs. Cellular CTPs and vs. Acellular CTPs.
  • Dr. Charles Ananian, DPM commented, "This new study cements what I have seen in my practice with the GRAFIX Membrane products.
  • GRAFIX PL and GRAFIX Membranes are human placental tissue products composed of native living cells, growth factors and an intact extracellular matrix.
  • To learn more about the GRAFIX Membrane portfolio of products and see the evidence, visit www.grafixpl.com .

BETMGM TO HOLD BUSINESS UPDATE EVENT

Retrieved on: 
Tuesday, March 29, 2022
Company, Partnership, MGM Resorts International, MGM, Group, News media, PartyCasino, NYSE, Borgata, ESG, Investor relations, Sports Interactive, EDT, Webcast, Karhu (sports brand), Communication, Q&A, Entain, Magazine, Gambling, Carbon, Foxy Bingo, LLC, Industry, Technology, Twitter, FTSE100, GMA New Media, FTSE4Good Index, LSE, Fortune (magazine), IGaming Business, AA, Facebook, PDT, MSCI, Sport, Partypoker, Instagram, Ladbrokes Coral, DJSI, Online gambling, Public relations, Sportingbet, Gala Bingo

LAS VEGAS, March 29, 2022 /PRNewswire/ --BetMGM LLC("BetMGM"), a leading sports betting and iGaming operator, will host a business update event for analysts and investors on Thursday, May 12, 2022 at 11 a.m. EDT (8 a.m. PDT / 4 p.m. BST).

Key Points: 
  • LAS VEGAS, March 29, 2022 /PRNewswire/ --BetMGM LLC("BetMGM"), a leading sports betting and iGaming operator, will host a business update event for analysts and investors on Thursday, May 12, 2022 at 11 a.m. EDT (8 a.m. PDT / 4 p.m. BST).
  • BetMGM is a market leading sports betting and gaming entertainment company, pioneering the online gaming industry.
  • Utilizing Entain's U.S.-licensed, state of the art technology, BetMGM offers sports betting and online gaming via market leading brands including BetMGM, Borgata Casino, Party Casino and Party Poker.
  • The Company's 50/50 venture, BetMGM, LLC, offers U.S. sports betting and online gaming through market-leading brands, including BetMGM and partypoker.

EQONEX Appoints New CEO as part of its Strategic Partnership with Bifinity

Retrieved on: 
Thursday, March 17, 2022
UNIDO, Solution, Technology, United Kingdom, Investment, Partnership, Goodwill, Sustainability Accounting Standards Board, FTSE100, Pan Africa Christian University, Compliance, NFT, History, NASDAQ, Head, Group, Board, United Nations Industrial Development Organization, CEO, Andrew Kerr (festival co-founder), FCA, Social media, Industry, Ecosystem, LinkedIn, Cryptocurrency, Management, Risk management, Made, Binance

SINGAPORE, March 17, 2022 /PRNewswire/ -- EQONEX Limited (NASDAQ: EQOS) ("EQONEX" or the "Company"), a digital assets financial services company, and Bifinity UAB ("Bifinity"), a payments technology company that is part of Binance, took the next step in solidifying their strategic partnership with the appointment of  EQONEX's new CEO and two new members to the EQONEX Board of Directors (the "Board").

Key Points: 
  • Jonathan Farnell, who previously served as Head of Binance UK and CEO of Bifinity, has been appointed as CEO of EQONEX and a director on the Board.
  • The current interim CEO Andrew Eldon will revert back to his primary roles of Chief Operating Officer and interim Chief Marketing Officer.
  • Under the terms of the strategic partnership announced last week, Bifinity had the right to nominate key appointments, including the CEO and two new Board members.
  • Their appointments mark the next critical step in developing the Bifinity and EQONEX strategic partnership.

Endeavour Appoints Srinivasan Venkatakrishnan as Chair and Ian Cockerill as Senior Independent Director

Retrieved on: 
Wednesday, March 16, 2022
Bachelor of Science, Time, Metal, Imperial College London, Royal School of Mines, Orica, AngloGold Ashanti, World Gold Council, African, Board, Chair, CEO, London Stock Exchange, SID, Lead, Mining, UK Corporate Governance Code, Commerce, FTSE100, Gold Fields, Royal School, National Strategic and Critical Minerals Production Act of 2013, LSE, Group, Leadership, Chairperson, Weir Group, Growth, TSX, Srinivasan Venkatakrishnan, Â, Director, Master of Science, International Council on Mining and Metals, Senior, BlackRock, BHP, Polymetal International, Chartered accountant, Anglo-Americans, Advanced Management Program, JSE Limited, Templeton College, Oxford, Company, Natural Resources, OTCQX, Industry, International Council, Gold, Management, Renewable energy, University of London, Endeavour, Venkata, Geology

London, 16 March 2022 Endeavour Mining plc (LSE:EDV, TSX:EDV, OTCQX:EDVMF) (Endeavour or the Company) is pleased to announce the appointment of Srinivasan Venkatakrishnan (Venkat) as an Independent Non-Executive Director and Chair of the Board and Ian Cockerill as the Senior Independent Non-Executive Director (SID).

Key Points: 
  • London, 16 March 2022 Endeavour Mining plc (LSE:EDV, TSX:EDV, OTCQX:EDVMF) (Endeavour or the Company) is pleased to announce the appointment of Srinivasan Venkatakrishnan (Venkat) as an Independent Non-Executive Director and Chair of the Board and Ian Cockerill as the Senior Independent Non-Executive Director (SID).
  • Ian Cockerill rejoins the Endeavour Board as the SID, having served as a Non-Executive Director between September 2013 and March 2019.
  • Srinivasan Venkatakrishnan, Chair Elect, said: It is a great honour to take on the role of Chair of Endeavour, a company Ive admired for some time.
  • Ian Cockerill rejoins the Endeavour Board as the SID, having served as a Non-Executive Director between September 2013 and March 2019.

XENIA HOTELS & RESORTS ANNOUNCES THE APPOINTMENT OF ARLENE ISAACS-LOWE TO ITS BOARD OF DIRECTORS

Retrieved on: 
Tuesday, March 15, 2022
U.S. Securities and Exchange Commission, MBA, Risk, MetLife, Sumathi Best Television Current Reporting Award, Corporate social responsibility, XHR, Moody Foundation, Annual report, Board of directors, Howard University, Moody's Investors Service, Special, CFA Institute, Compass, Private Securities Litigation Reform Act, Moody's Corporation, Uncertainty, Multimedia, Food, FTSE100, COVID-19, Xenia Hotels & Resorts, LLC, Securities Exchange Act of 1934, Compliance, Annual general meeting, Risk management, Safety, CPAS, Board, Fordham University, ESG, Company, Travel, Company secretary, View, NYSE, Securities Act of 1933, Software, REIT, Securities Analysts Association of China, CSR, Retirement, Management, Hotel, Director, Xenia

ORLANDO, Fla., March 15, 2022 /PRNewswire/ --Xenia Hotels & Resorts, Inc. (NYSE: XHR) ("Xenia" or the "Company") today announced the appointment of Ms. Arlene Isaacs-Lowe to its Board of Directors, effective March 14, 2022.

Key Points: 
  • ORLANDO, Fla., March 15, 2022 /PRNewswire/ --Xenia Hotels & Resorts, Inc. (NYSE: XHR) ("Xenia" or the "Company") today announced the appointment of Ms. Arlene Isaacs-Lowe to its Board of Directors, effective March 14, 2022.
  • With the appointment, the Company's Board of Directors increased to ten members, nine of whom are independent, including Ms. Isaacs-Lowe.
  • "On behalf of Xenia's Board of Directors and management team, I am pleased to welcome Arlene to our Board," commented Marcel Verbaas, Chairman and Chief Executive Officer of Xenia.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/xenia-hotels--resorts-announces...
    SOURCE Xenia Hotels & Resorts, Inc.

Smith+Nephew announces first surgery for its JOURNEY™ II Medial Dished System for total knee arthroplasty

Retrieved on: 
Thursday, February 10, 2022
Longevity, LSE, Smith & Nephew, U.S. Securities and Exchange Commission, Magnetic resonance imaging, NYSE, Cruciate ligament, Motion, United States patent law, Sports medicine, ENT, Failure, Instagram, Poster, SNN, LinkedIn, View, MD, Anterior cruciate ligament, PCL, TKA, Patent, Role, Comparison, Annual report, Twitter, Phrase, Technology, Patient, Form 20-F, Unlimited, Regeneration, Neacoryphus bicrucis, Robotics, United States Patent and Trademark Office, FTSE100, Veni, vidi, vici, Tom Takubo, General manager, NYU Langone Health, Multimedia, Fluoroscopy, Knee, Group, Gait, Patient satisfaction, Congress, Digital, Forward-looking statement, Medical device, Pharmaceutical industry, Sports equipment, Fused quartz, Medical imaging, Orthopedic surgery, Facebook, COVID-19

LONDON, Feb. 10, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the first completed surgery using its JOURNEY II Medial Dished (MD) System for total knee arthroplasty (TKA).

Key Points: 
  • LONDON, Feb. 10, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the first completed surgery using its JOURNEY II Medial Dished (MD) System for total knee arthroplasty (TKA).
  • "Our customers have expressed an interest in medial dished inserts and we are pleased to provide new treatment options that expand the clinical indications of the already successful JOURNEY II Knee System".
  • Smith+Nephew's JOURNEY II Medial Dished is now available in the United States for total knee replacement.
  • Iriuchishima T, Ryu K. A Comparision of Rollback Ratio between Bicruciate Substituting Total Knee Arthroplasty and Oxford Unicompartmental Knee Arthroplasty.

Smith+Nephew expands next-generation handheld robotic-assisted CORI™ Surgical System into total hip arthroplasty with RI.HIP NAVIGATION

Retrieved on: 
Wednesday, January 26, 2022
SNN, Hospital, NAVIGATION, Patent, United States Patent and Trademark Office, FTSE100, Longevity, Uwe Schmidt, Failure, View, Risk, CORI, United States patent law, Annual report, Patient, THA, ENT, Smith & Nephew, Arthroplasty, Poster, U.S. Securities and Exchange Commission, Isle, 3D ultrasound, Sports medicine, Group, LSE, Form 20-F, Twitter, Unlimited, Ambulatory Surgery Center Association, Computer, Adoption, Instagram, LinkedIn, Congress, Technology, Norma Kamali, Phrase, Forward-looking statement, NYSE, Robotics, Pulitzer Prize for International Reporting, Multimedia, Patient satisfaction, Osteoarthritis, General manager, Regeneration, McKinney, Texas, Medical device, Pharmaceutical industry, COVID-19, Facebook, Orthopedic surgery

Smith+Nephew's RI.HIP NAVIGATION - designed to help maximize accuracy and reproducibility by delivering patient-specific component alignment for THA is now available for use on its CORI System.

Key Points: 
  • Smith+Nephew's RI.HIP NAVIGATION - designed to help maximize accuracy and reproducibility by delivering patient-specific component alignment for THA is now available for use on its CORI System.
  • "We look forward to offering the possibility of further improving patient outcomes and satisfaction to a broader surgeon community with the rapidly expanding adoption of our CORI Surgical System."
  • Smith+Nephew's RI.HIP NAVIGATION recently received 510(k) clearance from the United States Food and Drug Administration for use on its CORI Surgical System.
  • Computer guided total hip arthroplasty is associated with a reduced risk of revision and increased patient satisfaction.